Metropolitan Life Insurance Company (MetLife)’s The Joint Corp JYNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-943
Closed -$12.3K 1098
2024
Q1
$12.3K Hold
943
﹤0.01% 2057
2023
Q4
$9.06K Hold
943
﹤0.01% 2211
2023
Q3
$8.48K Hold
943
﹤0.01% 2283
2023
Q2
$12.7K Buy
+943
New +$13.8K ﹤0.01% 2166
2023
Q1
Sell
-943
Closed -$13.2K 2394
2022
Q4
$13.2K Hold
943
﹤0.01% 2187
2022
Q3
$14.8K Hold
943
﹤0.01% 2163
2022
Q2
$14.4K Hold
943
﹤0.01% 2202
2022
Q1
$33.4K Sell
943
-2,953
-76% -$137K ﹤0.01% 1822
2021
Q4
$256K Hold
3,896
﹤0.01% 1845
2021
Q3
$382K Buy
+3,896
New +$365K 0.01% 1629
2021
Q2
Sell
-4,765
Closed -$230K 2794
2021
Q1
$230K Hold
4,765
﹤0.01% 1921
2020
Q4
$125K Hold
4,765
﹤0.01% 2236
2020
Q3
$82.9K Sell
4,765
-68
-1% -$1.11K ﹤0.01% 2325
2020
Q2
$73.8K Buy
+4,833
New +$63.3K ﹤0.01% 2416
2019
Q4
Sell
-5,160
Closed -$96K 2549
2019
Q3
$96K Buy
+5,160
New +$95.5K ﹤0.01% 2323

Other funds holding JYNT

Metropolitan Life Insurance Company (MetLife)'s JYNT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of The Joint Corp (JYNT) in Q2 2024, closing a stake of 943 shares — an estimated $12.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in JYNT in Q3 2019 and held it in 15 quarters. The position peaked at $382K in Q3 2021. 89 funds tracked by Wall St. Rank hold JYNT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining The Joint Corp position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 943 The Joint Corp shares in Q2 2024, an estimated $12.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in The Joint Corp in Q3 2019 and held it in 15 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s The Joint Corp position peaked at $382K in Q3 2021.
  • 89 funds tracked by Wall St. Rank held The Joint Corp as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.